Did Merck & Co. act appropriately back in 1999 when it discovered the dangers of heart attack and stroke associated with its product Vioxx? A new article published in today’s NPR puts that question to the test by questioning three renown scientists who are authorities on heart disease and clinical studies about the VIGOR study. For more information about this article on the VIGOR study click here
Vioxx: New Insight On The VIGOR Study
Did Merck & Co. act appropriately back in 1999 when it discovered the dangers of heart attack and stroke associated with its product Vioxx? A new article published in today’s NPR puts that question to the test by questioning three renown scientists who are authorities on heart disease and clinical s
M. Brandon Smith
Brandon Smith is a partner at Childers, Schlueter & Smith (CSS) in Atlanta, Georgia. He represents individuals nationwide in pharmaceutical litigation, mass torts, product liability, and serious personal injury cases.
All articles
Tags:
Prescription Drugs
More in Prescription Drugs
See all
More from M. Brandon Smith
See all
